The Traderszone Network

Published in TZ Latest News 25 June, 2015 by The TZ Newswire Staff

Illumina, A Gene Research Leader, In Buy Range

Shares of Illumina (ILMN) remain in buy range as the stock floats just above its most recent buy point. The stock is less than 5% above a 210.55 entry. The breakout occurred on June 5 as Illumina cleared a short handle formation in the pattern. Volume was below average that day but surged the next two days, which confirmed that institutional investors were accumulating shares.

read more